Details of Drug

Details of Drug

 Drug General Information (ID: D1778)
  Drug Name
Dotatate
  Drug Type Small molecule
  Drug Synonymous
Dotatate|DOTA-octreotate|DOTA-TATE|UNII-MRL3739G66|CHEMBL441920|MRL3739G66|177943-88-3|Oxodotreotide|DITA-TATE|DTXSID60170399|BDBM50165166|DB14554|Q5205896
    Click to Show/Hide
  Therapeutic Class Diagnostic Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C65H90N14O19S2
  InChI InChI=1S/C65H90N14O19S2/c1-38(80)56-64(96)73-51(63(95)75-57(39(2)81)65(97)98)37-100-99-36-50(72-59(91)47(28-40-10-4-3-5-11-40)68-52(83)32-76-20-22-77(33-53(84)85)24-26-79(35-55(88)89)27-25-78(23-21-76)34-54(86)87)62(94)70-48(29-41-15-17-43(82)18-16-41)60(92)71-49(30-42-31-67-45-13-7-6-12-44(42)45)61(93)69-46(58(90)74-56)14-8-9-19-66/h3-7,10-13,15-18,31,38-39,46-51,56-57,67,80-82H,8-9,14,19-30,32-37,66H2,1-2H3,(H,68,83)(H,69,93)(H,70,94)(H,71,92)(H,72,91)(H,73,96)(H,74,90)(H,75,95)(H,84,85)(H,86,87)(H,88,89)(H,97,98)/t38-,39-,46+,47-,48+,49-,50+,51+,56+,57+/m1/s1
  InChIKey QVFLVLMYXXNJDT-CSBVGUNJSA-N
  Canonical SMILES C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)O
  External Link
Pubchem ID 11170867

Drug-Drug Interaction Network
  Sunburst Graph
AM003  Affected organization distribution
BM014  Interference of cell/tissue uptake
  Relation Graph
 Full list of drugs interacting with Dotatate
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  3
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0891
 
Lanreotide
 
C54H69N11O10S2
 
71349 
Moderate    Inter Info   
[1]
D1163
 
Octreotide
 
C49H66N10O10S2
 
448601 
Moderate    Inter Info   
[1]
D1230
 
Pasireotide
 
C58H66N10O9
 
9941444 
Moderate    Inter Info   
[1]
References
1 Product Information. Netspot (dotatate). Advanced Accelerator Applications, New York, NY.